| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $32K | — |
| Cost of Revenue | $424K | — |
| R&D Expense | $340K | +22.3% |
| SG&A Expense | $873K | +21.6% |
| Operating Income | -$4.3M | +85.1% |
| Interest Expense | $793K | -25.5% |
| Pre-tax Income | -$14.4M | +41.6% |
| Income Tax | -$2.6M | -7918.2% |
| Net Income | -$11.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3K | -99.8% |
| Accounts Receivable | $5K | -97.5% |
| Inventory | $63K | — |
| Current Assets | $411K | -83.2% |
| Total Assets | $17.4M | -14.2% |
| Current Liabilities | $1.2M | -88.1% |
| Total Liabilities | $1.9M | -85.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | +51.8% |
| Investing Cash Flow | $3K | +50.0% |
| Financing Cash Flow | -$109K | -101.8% |
| +52.1% |
| EPS (Basic) | -$0.38 | +83.5% |
| EPS (Diluted) | -$0.38 | +83.5% |
| Stockholders' Equity |
| $12.6M |
| +196.1% |